Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79257091 |
Registration Number | 6010253 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Garrett Barten |
Attorney Docket Number | 1379-25TMP |
Law Office Assigned | O30 |
Employee Name | HUSSAIN, TASNEEM |
2019-01-09 | Application Filed |
2019-11-22 | Location: PUBLICATION AND ISSUE SECTION |
2019-12-31 | Published for Opposition |
2019-12-31 | Status: Live/Pending |
2019-12-31 | Transaction Date |
2020-03-17 | Trademark Registered |
Owner: | ![]() |
Address | Gottfried-Hagen-Str. 62 51105 Köln DE |
Legal Entity Type | Gesellschaft Mit Beschränkter Haftung (gmbh) |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0011 | Chemical, biological and biochemical substances, preparations and reagents for scientific research, laboratory research, industrial and commercial purposes, except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for researching and characterizing diseases except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for scientific and medical research and drug development except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for manufacturing drugs and pharmaceuticals, except chromatography chemicals and media, and except chemicals for use in separation and purification; cultures of microorganisms, proteins, polypeptides, nucleotides, nucleic acids, in particular plasmids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for scientific research, laboratory research, industrial and commercial purposes; all of the foregoing other than for medical or veterinary purposes |
GS0011 | Chemical, biological and biochemical substances, preparations and reagents for scientific research, laboratory research, industrial and commercial purposes, except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for researching and characterizing diseases except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for scientific and medical research and drug development except chromatography chemicals and media, and except chemicals for use in separation and purification; chemical, biological and biochemical substances, preparations and reagents for manufacturing drugs and pharmaceuticals, except chromatography chemicals and media, and except chemicals for use in separation and purification; cultures of microorganisms, proteins, polypeptides, nucleotides, nucleic acids, in particular plasmids, eukaryotic cell lines and eukaryotic cells, in particular transfected and/or selected eukaryotic cell lines and eukaryotic cells for scientific research, laboratory research, industrial and commercial purposes; all of the foregoing other than for medical or veterinary purposes |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-04-25 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-04-26 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2019-04-26 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2019-04-29 | 4 CNRT R:Renewal |
APPLICATION FILING RECEIPT MAILED | 2019-04-30 | 5 MAFR O:Outgoing Correspondence |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-04-30 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2019-05-25 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-05-25 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2019-06-14 | 9 RFNP P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-11-13 | 10 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-11-13 | 11 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-11-14 | 12 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-11-19 | 13 CNSA O:Outgoing Correspondence |
ASSIGNED TO LIE | 2019-11-20 | 14 ALIE A:Allowance for Publication |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-12-11 | 15 NONP E:E-Mail |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2019-12-18 | 16 OP2R P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-12-18 | 17 OPNS P: |
PUBLISHED FOR OPPOSITION | 2019-12-31 | 18 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-12-31 | 19 NPUB E:E-Mail |
NOTIFICATION PROCESSED BY IB | 2020-01-04 | 20 GPNX P: |
REGISTERED-PRINCIPAL REGISTER | 2020-03-17 | 21 R.PR A:Allowance for Publication |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-06-17 | 22 FICR P: |
FINAL DISPOSITION PROCESSED | 2020-07-27 | 23 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2020-07-27 | 24 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-08-14 | 25 FINO P: |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-06-11 | 26 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-06-11 | 27 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-06-11 | 28 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-06-11 | 29 TCCA I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-07-13 | 30 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-07-13 | 31 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-07-13 | 32 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-07-13 | 33 TCCA I:Incoming Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-08-21 | 34 COAR I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-08-21 | 35 CHAN I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-08-21 | 36 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-08-21 | 37 ARAA I:Incoming Correspondence |
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | 2023-08-21 | 38 EWOR I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2023-08-21 | 39 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-08-21 | 40 TCCA I:Incoming Correspondence |
NEW REPRESENTATIVE AT IB RECEIVED | 2023-11-19 | 41 NREP P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.